Pancreatic ductal adenocarcinoma microenvironment: Soluble factors and cancer associated fibroblasts as modulators of NK cell functions
- PMID: 39019404
- DOI: 10.1016/j.imlet.2024.106898
Pancreatic ductal adenocarcinoma microenvironment: Soluble factors and cancer associated fibroblasts as modulators of NK cell functions
Abstract
Pancreatic Ductal Adenocarcinoma (PDAC) is the most frequent pancreatic cancer and represents one of the most aggressive human neoplasms. Typically identified at advance stage disease, most PDAC tumors are unresectable and resistant to standard therapies. The immunosuppressive microenvironment in PDAC impedes tumor control but a greater understanding of the complex stromal interactions within the tumor microenvironment (TME) and the development of strategies capable of restoring antitumor effector immune responses could be crucial to fight this aggressive tumor and its spread. Natural Killer (NK) cells play a crucial role in cancer immunosurveillance and represent an attractive target for immunotherapies, both as cell therapy and as a pharmaceutical target. This review describes some crucial components of the PDAC TME (collagens, soluble factors and fibroblasts) that can influence the presence, phenotype and function of NK cells in PDAC patients tumor tissue. This focused overview highlights the therapeutic relevance of dissecting the complex stromal composition to define new strategies for NK cell-based immunotherapies to improve the treatment of PDAC.
Keywords: Cancer associated fibroblasts; Collagen; Immunotherapy; Natural killer cells; Pancreatic cancer; Tumor microenvironment.
Copyright © 2024. Published by Elsevier B.V.
Conflict of interest statement
Declaration of competing interest The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Similar articles
-
Targeting Triple NK Cell Suppression Mechanisms: A Comprehensive Review of Biomarkers in Pancreatic Cancer Therapy.Int J Mol Sci. 2025 Jan 9;26(2):515. doi: 10.3390/ijms26020515. Int J Mol Sci. 2025. PMID: 39859231 Free PMC article. Review.
-
Exploring the role of antigen-presenting cancer-associated fibroblasts and CD74 on the pancreatic ductal adenocarcinoma tumor microenvironment.Med Oncol. 2024 Nov 25;42(1):15. doi: 10.1007/s12032-024-02564-6. Med Oncol. 2024. PMID: 39585543 Review.
-
An Immunological Glance on Pancreatic Ductal Adenocarcinoma.Int J Mol Sci. 2020 May 8;21(9):3345. doi: 10.3390/ijms21093345. Int J Mol Sci. 2020. PMID: 32397303 Free PMC article. Review.
-
Mesothelin CAR T Cells Secreting Anti-FAP/Anti-CD3 Molecules Efficiently Target Pancreatic Adenocarcinoma and its Stroma.Clin Cancer Res. 2024 May 1;30(9):1859-1877. doi: 10.1158/1078-0432.CCR-23-3841. Clin Cancer Res. 2024. PMID: 38393682 Free PMC article.
-
Tumor immune microenvironment in pancreatic ductal adenocarcinoma revisited - Exploring the "Space".Cancer Lett. 2025 Jul 10;622:217699. doi: 10.1016/j.canlet.2025.217699. Epub 2025 Apr 7. Cancer Lett. 2025. PMID: 40204149 Review.
Cited by
-
Machine learning-based prognostic modelling of NK cells in PAAD for immunotherapy guidance.Discov Oncol. 2025 Apr 20;16(1):577. doi: 10.1007/s12672-025-02266-z. Discov Oncol. 2025. PMID: 40253675 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical